Genentech’s $2-billion North Carolina biomanufacturing expansion mid-build tests how power, water and labor constraints are shaping advanced manufacturing construction.
A Feb. 5 federal advisory review puts floodplain constraints, early engineering decisions and a $3.7B redevelopment framework into focus for the proposed RFK stadium.
As design review restarts, Trump’s planned White House ballroom exposes how privately funded additions can trigger federal obligations—and budget pressures—beyond their stated scope.
Builders’ risk insurance is no longer a backstop as higher deductibles and tighter underwriting are reshaping how owners and contractors manage risk on active jobsites.